The simultaneous assessment of quantitative indexes of insulin secretion an
d action in a single individual is important when quantifying their relativ
e role in the evolution of glucose tolerance in different physiopathologica
l states. Available methods quantify these indexes in relatively nonphysiol
ogical conditions, e.g., during glucose clamps or intravenous glucose toler
ance tests. Here, we present a method based on a physiological test applica
ble to large-scale genetic and epidemiologic studies-the oral glucose toler
ance test (OGTT). Plasma C-peptide, insulin, and glucose data from a freque
ntly sampled OGTT with 22 samples throughout 300 min (FSOGTT(300-22)) were
analyzed in 11 subjects with various degrees of glucose tolerance. In each
individual, two indexes of pancreatic sensitivity to glucose (Phi (s) [10(9
) min(-1)] and Phi (d) [10(9)]) and the insulin sensitivity index (S-I) (10
(5) dl/kg per min per pmol/l) were estimated by using the minimal model of
C-peptide secretion and kinetics originally proposed for intravenous graded
glucose infusion and the minimal model approach recently proposed for meal
/OGTTs. The indexes obtained from FSOGTT(300-22) were used as a reference f
or internal validation of OGTT protocols with reduced sampling schedules. O
ur results show that 11 samples in a 300-min period (OGTT(300-11)) is the t
est of choice because the indexes it provides (Phi (s) = 36 +/- 3 [means +/
- SE]; Phi (d) = 710 +/- 111; S-I = 10.2 +/- 2.4) show excellent correlatio
n and are not statistically different from those of FSOGTT(300-22) (Phi (s)
= 33 +/- 3; Phi (d) = 715 +/- 120; S-I = 10.1 +/- 2.3). In conclusion, OGT
T(300-11), interpreted with C-peptide and glucose minimal models, provides
a quantitative description of beta -cell function and insulin sensitivity i
n a single individual while preserving the important clinical classificatio
n of glucose tolerance provided by the standard 120-min OGTT.